G. Walmsley Graham
CIK 1777517 · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.34M
Companies
3
Total Filings
37
Lifetime Open-Market Net
$60.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-20 | OLMA | Buy (P) | — | $0 | EDGAR |
| 2020-11-19 | OLMA | Mixed | — | $0 | EDGAR |
| 2020-07-21 | ALXO | Mixed | +3,080,901 | $18.52M | EDGAR |
| 2020-07-17 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-01 | Akero Therapeutics, Inc. (AKRO) Delisted | Exer (M) | +2,168 | $43.3K | EDGAR |
| 2019-11-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.